THERANOSTICS 2016* , ,
Presentations this author is a contributor to:
177Lu-DKFZ-PSMA-617 therapy in metastatic castration resistant prostate cancer: safety, efficacy and quality of life assessment. (#27)
1:45 PM
Madhav Yadav
A New Era of Prostate Cancer Imaging - (submitted abstract)
Post-therapeutic dosimetry of 177Lu-DKFZ-PSMA-617 in treatment of patients with castration resistant prostate cancer (#91)
8:30 AM
Sanjana Ballal
Conference Breakfast: Moderated Poster Walk - Prostate tumours
To evaluate the role of Lutetium-177 (Lu-177) tin colloid radiosynovectomy (RSV) in patients with inflammatory knee joint conditions who are not responding to conventional modalities in a setup where Re-188 & Y-90 not available. (#122)
8:30 AM
Shamim Ahmed Shamim
Conference Breakfast: Moderated Poster Walk - Novel Theranostics